ClinicalTrials.Veeva

Menu

Thromboelastography-derived Functional Fibrinogen Levels (TEG-FF)

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Reducing Excess Blood Transfusion
Coagulation Status of Cardiac Surgery Patient
Focus of Study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirements

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective cardiac surgery patients who are undergoing primary cardiac surgery

Exclusion criteria

  • Emergency surgery
  • Re-operative cardiac surgery
  • History of hypercoagulable state as defined in medical record
  • Anticoagulated status at time of surgery
  • Plasma requirement prior to discontinuation of bypass (alters fibrinogen level)

Trial design

51 participants in 1 patient group

Cardiac surgery with cardiopulmary bypass

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems